Claim Missing Document
Check
Articles

Found 2 Documents
Search

Active Male Smoker with Active Pulmonary Tuberculosis, COPD, Covid-19, Klebsiella Pneumonia, Multiple Bullae and Secondary Bilateral Pneumothorax Mohammad Faridza Setyo Hadikusumab; Susanthy Djajalaksana; Rezki Tantular; Dini Rachma Erawati
Malang Respiratory Journal Vol. 7 No. 2 (2025): Volume 7 No 2, September 2025 Edition
Publisher : Universitaas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.mrj.2025.007.02.02

Abstract

Introduction: The first reported case in the world of an active male smoker with active pulmonary tuberculosis, chronic obstructive pulmonary disease (COPD), Covid-19, Klebsiella pneumonia, multiple bullae and secondary bilateral pneumothorax. The clinical presentation of secondary bilateral pneumothorax is highly variable, ranging from mild shortness of breath to tension pneumothorax and can result in very severe conditions. This case report aims to discuss the clinical challenges, diagnostic, and treatment approach, as well as follow-up of a male smoker diagnosed with active pulmonary TB, COPD, Covid-19, Klebsiella pneumonia, multiple bullae, and secondary bilateral pneumothorax. Case: Patient’s history, physical examination, supportive examination, and management strategies were documented and analyzed. A 47-year-old male active smoker with a history of shortness of breath in the last 2 weeks which has gotten worse since the last 1 day. The patient came to Lawang Hospital, an x-ray showed left tension pneumothorax, then was referred to Saiful Anwar Hospital. CXR from Saiful Anwar Hospital shows bilateral pneumothorax with left tension pneumothorax. The patient underwent two chest tube insertions with an interval of 2 days between insertions. The covid-19 PCR results were positive. Sputum bacteriological test showed Klebsiella pneumoniae infection. Thorax CT-scan with contrast showed multiple cysts and bullae on bilateral hemithorax and bilateral ground glass opacity on tree in bud with suspected active pulmonary TB. The bacteriological examination for tuberculosis was negative with a suspicion of COPD due to an active smoking habit. The patient is still being treated with anti-tuberculosis drugs, antibiotics, and antivirals, and showed improvement. Conclusion: Cases of secondary bilateral pneumothorax with active pulmonary TB, COPD, Covid-19, Klebsiella pneumonia, multiple bullae in active smoking patients with subtle clinical features are quite rare, which frequently results in misdiagnosis during thoracic assessments and may exacerbate the patient's condition. Clinicians must remain vigilant for potential underlying diseases in such cases.
Differences in Serum Soluble Cluster of Differentiation 163 levels and Monocyte Lymphocyte Ratio between Drug-Resistant and Drug-Sensitive Lung Tuberculosis Nuansa Paramita; Ngakan Putu Parsama Putra; Susanthy Djajalaksana; Rezki Tantular; Ani Budi Astuti
Jurnal Respirologi Indonesia Vol 46 No 4 (2026)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/

Abstract

Background: Tuberculosis (TB) remains a major health problem, particularly in Indonesia. Early diagnosis of drug-sensitive (DS-TB) and drug-resistant tuberculosis (DR-TB) remains challenging due to limited access to molecular diagnostics in peripheral healthcare settings and difficulties in sputum specimen collection. This study evaluated serum soluble CD163 (sCD163) and monocyte-to-lymphocyte ratio (MLR) for diagnostic utility. Methods: A cross-sectional study included 32 DS-TB patients, 30 DR-TB patients, and 26 healthy controls. Serum sCD163 was measured using ELISA, while MLR was calculated from complete blood counts. Statistical analyses included Kruskal–Wallis, Dunn's post hoc, Spearman correlation, and Cross Tabulation analysis for each comparisons. Results: Both DR-TB and DS-TB showed significantly higher sCD163 levels than controls (p=0.003), with no difference between TB groups (p=0.676). Similarly, MLR was higher in both TB groups than controls (p<0.001), without intergroup differences (p=0.217). Serum sCD163 positively correlated with MLR (r=0.319; p=0.003). Patients with sCD163 >85.97 ng/mL and MLR >0.59 had 1.01-fold and 1.29-fold higher odds of DR-TB, respectively, although these associations were not statistically significant. sCD163 in DR-TB showed slightly lower sCD163 and MLR than DS-TB. This may reflect a more preserved innate immune response with active monocyte–macrophage activation in DS-TB, whereas chronic antigen exposure in DR-TB may induce immune dysregulation and immune exhaustion, reducing monocyte activity and biomarker release. Conclusion: sCD163 and MLR may serve as supportive biomarkers for active TB diagnosis especially DR-TB, with MLR showing greater diagnostic value.